Enhanced serum interferon-lambda 1/interleukin-29 levels in patients with psoriasis vulgaris
Abstract Background: Interferon (IFN)-λ1, also named Interleukin (IL)-29, is a new member of the Type III IFN or IFN-λ family. IL-29 plays an important role in the pathogenesis of many types of autoimmune and inflammatory diseases. Objective: To study the role of IL-29 in the pathogenesis of psorias...
Saved in:
Main Authors: | Li-xin Fu (Author), Tao Chen (Author), Zai-Pei Guo (Author), Na Cao (Author), Li-Wen Zhang (Author), Pei-Mei Zhou (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels
by: Diana Castillo-Martínez, et al.
Published: (2017) -
Lambda Interferons: New Cytokines with Old Functions
by: Ole J. Hamming, et al.
Published: (2010) -
Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019) -
Imbalance between serum interleukin-36 and interleukin-38 is associated with metabolic syndrome in psoriasis vulgaris
by: Marwa A Amer, et al.
Published: (2023) -
Interferon-Lambda 1 Inhibits Staphylococcus aureus Colonization in Human Primary Keratinocytes
by: Xia Wu, et al.
Published: (2021)